Dan Scott, vice president of Credit Suisse, discusses what is really driving mergers and acquisitions around the globe.» Read More
CFOs expect to see a modest improvement in the economy over the next six months but not much of a dent in employment. Read the full results of the CNBC Global CFO Council.
If Dell's board considers buyout offers from Blackstone Group or Carl Icahn superior to Michael Dell's offer, some think Dell could up his price. However, options traders aren't buying it.
A television consultant claims that former Vice President Al Gore and others at Current TV stole his idea to sell the struggling network to Al-Jazeera.
Financial services firms have been operating in a financial "Groundhog Day" of sorts for nearly five years – one that, at TD Ameritrade, has a direct impact on almost 50 percent of our revenue stream.
Irish drugmaker Elan has sweetened the terms on offer to shareholders under its $3.25 billion disposal plan, as it aims to stave off an approach for the company from U.S. investment firm Royalty Pharma.
With debt cheap and plenty of cash on the books, companies are primed to make deals when they are good and ready.
The traditional view of a chief financial officer is a bean counter focused on company finances. But the finance function is transforming from being known for saying 'no' to big projects to taking a role in growth and development.
Best Buy founder Richard Schulze's effort to take the company private is in trouble after attempts to secure financing faltered, while an alternative strategy to line up minority investors may not pan out either, Reuters reported.
With approximately 1.2 Trillion dollars in cash sitting on the books of non-financial firms, CFOs need to ensure their cash is efficiently deployed. Is it possible with all of this liquidity?
Consider chief financial officers as the ones manning the front lines in the battle against black swans.
Royalty Pharma has made a $6.6 billion bid to buy Elan, seeking to scupper the drugmaker's plan to spend most of the proceeds from a major drug sale on deals.
“All went from being benign to pernicious in one week,” said Jim Cramer. “Is that possible?”
The head of U.S. tire maker Titan launched a vitriolic attack on French productivity after the country’s government suggested he buy a factory in the north of France.
A British-based private equity consortium is preparing a bid of 3.5 billion euros for French catering company Elior in what would be the biggest buyout in continental Europe since Lehman Brothers collapsed in 2008.
Media giant Gannett announced on Thursday that it was merging with television station Belo, in a $1.5 billion deal that would expands Gannett's reach into broadcast.
Empire, operator of Canadian grocery chain Sobeys, plans to acquire Safeway's assets in Canada for billions, nearly doubling its reach in the Canadian western provinces.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching Thursday.
The Fast Money traders share their final trades of the day.
The Fast Money traders take a look at today's biggest market movers.
Get the best of CNBC in your inbox